BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21987594)

  • 21. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
    Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H
    Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current therapeutic targets for the treatment of Alzheimer's disease.
    Grill JD; Cummings JL
    Expert Rev Neurother; 2010 May; 10(5):711-28. PubMed ID: 20420492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease 2012: the great amyloid gamble.
    Marchesi VT
    Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on pharmacotherapy of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alzheimer disease: from pathogenetic issues to clinical perspectives].
    Costanza A; Bouras C; Kövari E; Giannakopoulos P
    Rev Med Suisse; 2012 Sep; 8(354):1770-2, 1774. PubMed ID: 23097914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics.
    Sala Frigerio C; De Strooper B
    Annu Rev Neurosci; 2016 Jul; 39():57-79. PubMed ID: 27050320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of tau-directed small molecule modulators for Alzheimer's disease: a recent patent review (2014-2018).
    Lee HE; Lim D; Lee JY; Lim SM; Pae AN
    Pharm Pat Anal; 2019 Jan; 8(1):15-39. PubMed ID: 30870110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating metals as a therapeutic strategy for Alzheimer's disease.
    Hung LW; Barnham KJ
    Future Med Chem; 2012 May; 4(8):955-69. PubMed ID: 22650238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Karran E; Mercken M; De Strooper B
    Nat Rev Drug Discov; 2011 Aug; 10(9):698-712. PubMed ID: 21852788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review.
    Caltagirone C; Ferrannini L; Marchionni N; Nappi G; Scapagnini G; Trabucchi M
    Aging Clin Exp Res; 2012 Dec; 24(6):580-7. PubMed ID: 22961121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
    Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
    Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Curative treatment of Alzheimer's disease is still missing--is amyloid plaque hypothesis the wrong starting point?].
    Tanila H
    Duodecim; 2015; 131(3):243-8. PubMed ID: 26245074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Landmark Alzheimer's drug approval confounds research community.
    Mullard A
    Nature; 2021 Jun; 594(7863):309-310. PubMed ID: 34103732
    [No Abstract]   [Full Text] [Related]  

  • 38. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolving controversies on the path to Alzheimer's therapeutics.
    Selkoe DJ
    Nat Med; 2011 Sep; 17(9):1060-5. PubMed ID: 21900936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amyloid hypothesis on trial.
    Makin S
    Nature; 2018 Jul; 559(7715):S4-S7. PubMed ID: 30046080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.